Bottle PEP in Cystic Fibrosis

The study aims to investigate the sustainability of Bottle-PEP in patients with cystic fibrosis

Completed

Looking for future studies?

Key information

Conditions

Cystic Fibrosis Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Lung Diseases Pancreatic Diseases Respiratory Tract Diseases

Age range

6 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Marmara University School of Medicine Department of Physical Medicine and Rehabilitation

Istanbul, 34899, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of cystic fibrosis
Acute exacerbation

Exclusion criteria

Any contraindication using the Bottle - PEP such as the presence of pneumothorax

Treatment and study plan

Bottle-PEP

Other

A device that gives positive pressure from a bottle with the help of a non deflating tube

Routine physiotherapy

Other

Routine pulmonary physiotherapy

Primary outcomes

6 minute walk test

Time frame: every 3 months

distance of meters walked in 6 minutes

Sponsors and collaborators

Lead sponsor

Marmara University

Other

Registry information

Official study title

Safety and Sustainability in Bottle PEP in Cystic Fibrosis

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Jul 14, 2021
Registry last updated: Jul 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed